In ER/PR- human breast cancer, which also is not driven by viral infections, NLRX1 enhanced aggressive in vitro cancer-associated phenotypes through augmenting mitochondrial respiration and reducing mitophagy and lysosomal formation and function through mitochondria-lysosomal crosstalk (32). Here, NLRX1 is linked to viral infectious disease.